Alexza Pharmaceuticals Inc. Obligations, Fair Value Disclosure
Alexza Pharmaceuticals Inc. had Obligations, Fair Value Disclosure of $50.03 million as of 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations · last filed 2016-05-13
- 2016-03-31: Obligations, Fair Value Disclosure $50.03M.
- 2015-12-31: Obligations, Fair Value Disclosure $52.15M.
- 2015-09-30: Obligations, Fair Value Disclosure $50.38M.
- 2015-06-30: Obligations, Fair Value Disclosure $46.33M.
| Period end | Obligations, Fair Value Disclosure |
|---|---|
| 2016-03-31 | $50.03M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $52.15M 10-Q · filed 2016-05-13 |
| 2015-09-30 | $50.38M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $46.33M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $51.58M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $52.08M 10-K · filed 2016-03-28 |
| 2014-09-30 | $54.69M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $56.13M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $50.83M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $9.34M 10-K · filed 2015-03-13 |
| 2013-09-30 | $6.13M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $3.15M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.73M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $6.25M 10-K · filed 2014-03-25 |
| 2012-09-30 | $7.71M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $9.11M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $11.72M 10-K · filed 2013-03-26 |